
Tarsier Pharma
Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.
About
Tarsier Pharma is a late clinical-stage company developing bio-inspired medical solutions for autoimmune and inflammatory ocular diseases. Their breakthrough platform technology, Dazdotuftide (TRS), aims to re-engineer the immune system to treat conditions like uveitis, with a pipeline including eye drops and intravitreal injections. They serve patients suffering from blinding ocular diseases and provide information for healthcare providers and investors.
Listed competitors
Also in this space
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Healthcare, Biotech
Develops a computational model of the human body for drug discovery and development.
Shares Healthcare, Drug Discovery
AI-powered spatial biology platform for precision medicine and drug development.
Shares Healthcare, HealthTech
Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.
Shares Healthcare, Biotech
AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.
Shares Healthcare, Biotech
Digital therapeutics platform enhancing drug efficacy and safety through personalized software.
Shares Healthcare, Biotech
Key facts
- Website
- tarsierpharma.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2016
- Employees
- 12
- Total funding
- $5M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jun 2021 | Series B | $5M |
Tech stack
Detected on tarsierpharma.com, last scanned 18 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Tarsier Pharma scores 35. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Tarsier Pharma trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Tarsier Pharma is 74 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Tarsier Pharma raised?
Tarsier Pharma has raised a total of $5M in funding. The most recent round on record is Series B.
How many employees does Tarsier Pharma have?
Tarsier Pharma has approximately 12 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Tarsier Pharma


